The Acquisition of Worldwide Rights to Vecoxan®
We are pleased to announce that we have made an exciting addition to our ruminant parasiticide portfolio. We have completed the acquisition of worldwide rights to VECOXAN® (diclazuril), an oral suspension for the prevention of coccidiosis in calves and lambs. This acquisition will bolster our portfolio offerings for parasite control and protection, which are paramount […]